Download PDF
DO - Deutsche Zeitschrift für Osteopathie 2021; 19(04): 4-10
DOI: 10.1055/a-1346-4567
Praxis
Mammakarzinom

Osteopathische Überlegungen zur Begleitung der Therapie des Mammakarzinoms

Anja Engel-Schulmeyer
› Further Information
Also available at
    Permissions and Reprints

Die allopathische Therapie beim Mammakarzinom teilt sich in 3 Phasen: neoadjuvante Chemotherapie (zur präoperativen Tumorreduktion), Mastektomie und Radiotherapie. Phasenübergreifend kommt zusätzlich eine Hormontherapie zur Anwendung. Die Medikation bzw. das Therapieverfahren erzeugt in jeder Phase spezifische Beschwerden. Für diese werden osteopathische Behandlungsansätze unter Berücksichtigung bereits vorliegender Evidenz beschrieben.

Publication History

Article published online:
16 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Schem C, Jonat W, Maass N. Maligne Tumoren der Mamma. In: Petru E, Fink D, Köchli R, Loibl S. Praxisbuch Gynäkologische Onkologie. Berlin: Springer; 2019
    CrossrefGoogle Scholar
  • 2 Krawczyk N, Banys-Paluchowski M, Fehm T. Triple-negatives Mammakarzinom – neue Behandlungsstrategien. Der Gynäkologe 2020; 53: 771-779
    CrossrefGoogle Scholar
  • 3 de Groot S, Pijl H, van der Hoeven JJM. et al. Effects of short-term fasting on cancer treatment. J Exp Clin Cancer Res 2019; 38: 209
    CrossrefPubMedGoogle Scholar
  • 4 Sremanakova J, Sowerbutts AM, Burden S. A systematic review of the use of ketogenic diets in adult patients with cancer. J Hum Nutr Diet 2018; 31 (06) 793-802
    CrossrefPubMedGoogle Scholar
  • 5 Caccialanza R, Cereda E, De Lorenzo F. et al. To fast, or not to fast before chemotherapy, that is the question. BMC Cancer 2018; 18: 337
    CrossrefPubMedGoogle Scholar
  • 6 OʼFlanagan CH, Smith LA, McDonell SB. et al. When less may be more: calorie restriction and response to cancer therapy. BMC Med 2017; 15 (01) 106
    CrossrefPubMedGoogle Scholar
  • 7 http://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/chemotherapy-safety.htm Stand: 1.6.2021
  • 8 Yuki M, Sekine S, Takase K. et al. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients. J Oncol Pharm Pract 2013; 19 (03) 208-217
    CrossrefPubMedGoogle Scholar
  • 9 Speece CA, Crow WT, Simmons SL. Osteopathische Körpertechniken nach W.G. Sutherland: Ligamentous Articular Strain. Stuttgart: MVS; 2003
    Google Scholar
  • 10 Buekens J. Bone – The best kept secret. School of Bones; 2020
    Google Scholar
  • 11 Billhult A, Bergbom I, Stener-Victorin E. Massage relieves nausea in women with breast cancer who are undergoing chemotherapy. Journal of alternative and complementary medicine 2007; 13 (01) 53-57
    CrossrefPubMedGoogle Scholar
  • 12 Dibble SL, Chapman J, Mack KA. et al. Acupressure for nausea: results of a pilot study. Oncol Nurs Forum 2000; 27 (01) 41-47
    PubMedGoogle Scholar
  • 13 Favier N, Guinet A, Nageleisen M. et al. Secondary effects and quality of life with chemotherapy: assessing the impact of an osteopathic treatment (multicentric randomized clinical trial). Russian Osteopathic Journal 2020; 3 – 4: 174-185
    CrossrefGoogle Scholar
  • 14 Lagrange A, Decoux D, Briot N. et al. Visceral osteopathic manipulative treatment reduces patient reported digestive toxicities induced by adjuvant chemotherapy in breast cancer: A randomized controlled clinical study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019; 241: 49-55
    CrossrefPubMedGoogle Scholar
  • 15 Chvetzoff G, Berthier A, Blanc E. et al. Osteopathy for chronic pain after breast cancer surgery: A monocentric randomised study. Bull Cancer 2019; 106 (05) 436-446
    PubMedGoogle Scholar
  • 16 Goyal M, Goyal K, Narkeesh K. et al. Osteopathic manipulative treatment for post mastectomy lymphedema: A case report. International Journal of Osteopathic Medicine 2017; 26: 49-52
    CrossrefGoogle Scholar
  • 17 Sphar BG, Bowe C, Dains JE. The Impact of Peripheral Cooling on Chemotherapy-Induced Peripheral Neuropathy: An Integrative Review. J Adv Pract Oncol 2020; 11 (08) 845-857
    PubMedGoogle Scholar
  • 18 Schaffler-Schaden D, Sassmann R, Johansson T. et al. Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy. Medicine 2020; 99 (19) e20149
    CrossrefPubMedGoogle Scholar
  • 19 http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/ Stand: 1.6.2021
  • 20 Moskovitz AH, Anderson BO, Yeung RS. et al. Axillary web syndrome after axillary dissection. Am J Surg 2001; 181 (05) 434-439
    CrossrefPubMedGoogle Scholar
  • 21 Ryans K. Incidence and predictors of axillary web syndrome and its association with lymphedema in women following breast cancer treatment: a retrospective study. Support Care Cancer 2020; 28 (12) 5881-5888
    CrossrefPubMedGoogle Scholar
  • 22 Yeung WM, McPhail SM, Kuys SS. A systematic review of axillary web syndrome (AWS). J Cancer Surviv 2015; 9 (04) 576-598
    CrossrefPubMedGoogle Scholar
  • 23 De Groef A, Van Kampen M, Dieltjens E. et al. Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil 2015; 96 (06) 1140-1153
    CrossrefPubMedGoogle Scholar
  • 24 McNeely ML, Campbell K, Ospina M. et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev 2010; (06) CD005211
    PubMedGoogle Scholar
  • 25 Meert GF. Das venöse und lymphatische System aus osteopathischer Sicht: Thorax, Abdomen, Becken, Extremitäten. München: Elsevier; 2007
    Google Scholar
  • 26 Standley PR, Meltzer K. In vitro modeling of repetitive motion strain and manual medicine treatments: potential roles for pro- and anti-inflammatory cytokines. J Bodyw Mov Ther 2008; 12 (03) 201-203
    CrossrefPubMedGoogle Scholar
  • 27 Bordoni B, Zanier E. Understanding Fibroblasts in Order to Comprehend the Osteopathic Treatment of the Fascia. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556860/ Stand: 1.6.2021
    Google Scholar
  • 28 Cowman MK, Schmidt TA, Raghavan P. et al. Viscoelastic Properties of Hyaluronan in Physiological Conditions. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648226/ Stand: 1.6.2021
    Google Scholar
  • 29 Fourie WJ, Robb KA. Physiotherapy management of axillary web syndrome following breast cancer treatment: Discussing the use of soft tissue techniques. Physiotherapy 2009; 95 (04) 314-320
    CrossrefPubMedGoogle Scholar
  • 30 Lederman E. Harmonische Techniken: Rhythmische Behandlung in der Osteopathie. München: Elsevier; 2006
    Google Scholar
  • 31 Williams PE. Effect of intermittent stretch on immobilised muscle. Annals of the Rheumatic Diseases 1988; 47 (12) 1014-1016
    CrossrefPubMedGoogle Scholar
  • 32 Geller BM, Vacek PM, OʼBrien P. et al. Factors Associated with Arm Swelling after Breast Cancer Surgery. Journal of Womenʼs Health 2003; 12 (09) 921-930
    CrossrefPubMedGoogle Scholar
  • 33 Burkhart SS, Morgan CD, Kibler WB. The disabled throwing shoulder: Spectrum of Pathology Part II: Evaluation and treatment of SLAP lesions in throwers. Arthroscopy: The Journal of Arthroscopic & Related Surgery 2003; 19 (05) 531-539
    CrossrefPubMedGoogle Scholar
  • 34 Hinrichs CS, Watroba NL, Rezaishiraz H. et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol 2004; 11 (06) 573-580
    CrossrefPubMedGoogle Scholar
  • 35 Miller CL, Specht MC, Skolny MN. et al. Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat 2014; 144 (01) 71-77
    CrossrefPubMedGoogle Scholar
  • 36 Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004; 187 (01) 69-72
    CrossrefPubMedGoogle Scholar
  • 37 Petrek J, Senie R, Peters M. et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92: 1368-1377
    CrossrefPubMedGoogle Scholar
  • 38 Querci della Rovere G, Ahmad I, Singh P. et al. An audit of the incidence of arm lymphoedema after prophylactic level I/II axillary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl 2003; 85 (03) 158-161
    CrossrefPubMedGoogle Scholar
  • 39 Werner RS, McCormick B, Petrek J. et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 1991; 180 (01) 177-184
    CrossrefPubMedGoogle Scholar
  • 40 Godette K, Mondry TE, Johnstone PAS. Can manual treatment of lymphedema promote metastasis?. J Soc Integr Oncol 2006; 4 (01) 8-12
    PubMedGoogle Scholar
  • 41 Ota KS. Postmastectomy lymphedema: a call for osteopathic medical research. J Am Osteopath Assoc 2006; 106 (03) 110-111
    PubMedGoogle Scholar
  • 42 Hull MM. Lymphedema in women treated for breast cancer. Semin Oncol Nurs 2000; 16 (03) 226-237
    CrossrefPubMedGoogle Scholar
  • 43 Stecco C. Atlas des menschlichen Fasziensystems. München: Elsevier; 2016
    Google Scholar
  • 44 Bagheri S, Ohlin K, Olsson G. et al. Tissue tonometry before and after liposuction of arm lymphedema following breast cancer. Lymphat Res Biol 2005; 3 (02) 66-80
    CrossrefPubMedGoogle Scholar
  • 45 Ezzo J, Manheimer E, McNeely ML. et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev 2015; (05) CD003475
    PubMedGoogle Scholar
  • 46 Vereecken P, Mathieu A, Laporte M. et al. Spread of melanoma after lymphatic drainage: relaunching the debate. Int J Clin Pract 2003; 57 (05) 444-445
    CrossrefPubMedGoogle Scholar
  • 47 Opipari M, Perotta A, Essig-Beatty D. Oncology. In: Foundations of Osteopathic Medicine. 2. Aufl.. Philadelphia: Lippincott, Williams & Wilkins; 2003
    Google Scholar
  • 48 Bergmann A, Baiocchi JMT, Rizzi SKL de A. et al. Drenagem Linfática Manual em Pacientes Oncológicos: Quais as Evidências Científicas e as Recomendações Clínicas?. Rev Bras Cancerol 2021; 67 (01) e-131055
    CrossrefGoogle Scholar
  • 49 de Vries D, Piller N, Dawson R. et al. Is there a link between LE treatment and breast cancer reoccurence?. Journal of Lymphoedema 2011; 2: 85-86
    Google Scholar
  • 50 Flor EM, Flor EM, Flor AM. Manual lymph drainage in patients with tumoral activity. Journal of Phlebology and Lymphology 2009; 2: 13-15
    Google Scholar
  • 51 Hsiao P-C, Liu J-T, Lin C-L. et al. Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort study. Ther Clin Risk Manag 2015; 11: 349-358
    CrossrefPubMedGoogle Scholar
  • 52 Ruiter DJ, van Krieken JH, van Muijen GN. et al. Tumour metastasis: is tissue an issue?. The Lancet Oncology 2001; 2 (02) 109-112
    CrossrefPubMedGoogle Scholar
  • 53 Kuchera M. Lymphatic approach. In: Chila AG. Foundations of osteopathic medicine. Philadelphia: Wolters Kluwer Health/Lippincott, Williams & Wilkins; 2011
    Google Scholar
  • 54 Zink J, Lawson W. The role of pectoral traction in the treatment of lymphatic flow disturbances. Osteopath Annals 1978; 6 (11) 493e6
    Google Scholar
  • 55 Hodge LM, Downey HF. Lymphatic pump treatment enhances the lymphatic and immune systems. Exp Biol Med 2011; 236 (10) 1109-1115
    CrossrefPubMedGoogle Scholar
  • 56 Knott EM, Oms V, Tune J. et al. Increased Lymphatic Flow in the Thoracic Duct During Manipulative Intervention. The Journal of the American Osteopathic Association 2005; 105 (10) 447-456
    PubMedGoogle Scholar
  • 57 Olszewski WL. Contractility Patterns of Human Leg Lymphatics in Various Stages of Obstructive Lymphedema. Annals of the New York Academy of Sciences 2008; 1131 (01) 110-118
    CrossrefPubMedGoogle Scholar
  • 58 Paepke D. Integrative Medizin in der gynäkologischen Onkologie. Gynäkologe 2021; 54 (01) 5-9
    CrossrefGoogle Scholar